RT @GilliesKatie: .@janjansenuk taking us through the evaluation of innovative technologies in small populations and the need for Bayesian…
RT @GilliesKatie: .@janjansenuk taking us through the evaluation of innovative technologies in small populations and the need for Bayesian…
RT @GilliesKatie: .@janjansenuk taking us through the evaluation of innovative technologies in small populations and the need for Bayesian…
RT @GilliesKatie: .@janjansenuk taking us through the evaluation of innovative technologies in small populations and the need for Bayesian…
.@janjansenuk taking us through the evaluation of innovative technologies in small populations and the need for Bayesian analytical frameworks. Flags the following paper from @MaxParmarMRCUCL @mattsydes and @tmorris_mrc as a helpful starting point https://
RT @MarionKCampbell: There are however a number of ways to maximise the information that can be gained in this scenario. Parmar et al devel…
RT @MarionKCampbell: There are however a number of ways to maximise the information that can be gained in this scenario. Parmar et al devel…
RT @MarionKCampbell: There are however a number of ways to maximise the information that can be gained in this scenario. Parmar et al devel…
RT @MarionKCampbell: There are however a number of ways to maximise the information that can be gained in this scenario. Parmar et al devel…
RT @MarionKCampbell: There are however a number of ways to maximise the information that can be gained in this scenario. Parmar et al devel…
RT @MarionKCampbell: There are however a number of ways to maximise the information that can be gained in this scenario. Parmar et al devel…
RT @MarionKCampbell: There are however a number of ways to maximise the information that can be gained in this scenario. Parmar et al devel…
RT @MarionKCampbell: There are however a number of ways to maximise the information that can be gained in this scenario. Parmar et al devel…
There are however a number of ways to maximise the information that can be gained in this scenario. Parmar et al developed a useful framework with practical approaches to help with this 3/8 https://t.co/8WeejypPRy https://t.co/UyhCqJwEHS
We have found this framework incredibly useful when designing trials in smaller/rare populations https://t.co/W8gptvdfqR
RT @mattsydes: The paper was published open access 🔓in 2016 in @BMCMedicine https://t.co/ApmZJpdaIr 3/8
RT @mattsydes: The paper was published open access 🔓in 2016 in @BMCMedicine https://t.co/ApmZJpdaIr 3/8
With the amazing @mrcctu Comms Team, we also put together a lovely visual which @BMCMedicine used https://t.co/9Af0xAd1nX 6/8 https://t.co/8Fgqe2mVOg
The paper was published open access 🔓in 2016 in @BMCMedicine https://t.co/ApmZJpdaIr 3/8
@ADAlthousePhD This paper has been a go to for me. Figure 1. When everything else is exhausted then recommendation to relax alpha https://t.co/qI0mOGBB39
This framework also helps thinking for "smaller" populations https://t.co/ApmZJpdaIr
RT @ADAlthousePhD: @akulkarnicardio @AriCedars @f2harrell 3. I think this paper from @tmorris_mrc has some good discussion of consideration…
RT @ADAlthousePhD: @akulkarnicardio @AriCedars @f2harrell 3. I think this paper from @tmorris_mrc has some good discussion of consideration…
RT @ADAlthousePhD: @akulkarnicardio @AriCedars @f2harrell 3. I think this paper from @tmorris_mrc has some good discussion of consideration…
RT @ADAlthousePhD: @akulkarnicardio @AriCedars @f2harrell 3. I think this paper from @tmorris_mrc has some good discussion of consideration…
RT @ADAlthousePhD: @akulkarnicardio @AriCedars @f2harrell 3. I think this paper from @tmorris_mrc has some good discussion of consideration…
RT @ADAlthousePhD: @akulkarnicardio @AriCedars @f2harrell 3. I think this paper from @tmorris_mrc has some good discussion of consideration…
RT @ADAlthousePhD: @akulkarnicardio @AriCedars @f2harrell 3. I think this paper from @tmorris_mrc has some good discussion of consideration…
RT @ADAlthousePhD: @akulkarnicardio @AriCedars @f2harrell 3. I think this paper from @tmorris_mrc has some good discussion of consideration…
RT @ADAlthousePhD: @akulkarnicardio @AriCedars @f2harrell 3. I think this paper from @tmorris_mrc has some good discussion of consideration…
@akulkarnicardio @AriCedars @f2harrell 3. I think this paper from @tmorris_mrc has some good discussion of considerations for designing RCT in smaller populations: https://t.co/pELAx8e97B
RT @MRCCTU: How do you design randomised trials for smaller populations? A framework https://t.co/5S2d0O5rqL https://t.co/mODchIxLrJ
How do you design randomised trials for smaller populations? A framework https://t.co/5S2d0O5rqL https://t.co/mODchIxLrJ
RT @MRCCTU: Today, 12.30pm: our #smallpopulations Q&A. Inspired by this @BMCMedicine article by Max, @tmorris_mrc and @mattsydes https://t.…
Today, 12.30pm: our #smallpopulations Q&A. Inspired by this @BMCMedicine article by Max, @tmorris_mrc and @mattsydes https://t.co/QWjQQfaMWS https://t.co/JxxFmfhgaU
RT @mattsydes: How to spend your Sat eve? Read: "How do you design randomised trials for smaller populations? A framework" https://t.co/W07…
RT @MRCCTU: Consider relaxing α: trial may be a once-in-a-generation chance to improve outcomes in a smaller population https://t.co/yYfMAb…
RT @munkee74: This got mentioned at PARCC #RareDisease meeting in Jan - tips for reducing sample size for #RCT: https://t.co/5n6MTqskGC
RT @munkee74: This got mentioned at PARCC #RareDisease meeting in Jan - tips for reducing sample size for #RCT: https://t.co/5n6MTqskGC
This got mentioned at PARCC #RareDisease meeting in Jan - tips for reducing sample size for #RCT: https://t.co/5n6MTqskGC
RT @MRCCTU: Consider relaxing α: trial may be a once-in-a-generation chance to improve outcomes in a smaller population https://t.co/yYfMAb…
RT @MRCCTU: Consider relaxing α: trial may be a once-in-a-generation chance to improve outcomes in a smaller population https://t.co/yYfMAb…
RT @MRCCTU: Consider relaxing α: trial may be a once-in-a-generation chance to improve outcomes in a smaller population https://t.co/yYfMAb…
Consider relaxing α: trial may be a once-in-a-generation chance to improve outcomes in a smaller population https://t.co/yYfMAb2DZq https://t.co/qdU1sphPK4
Designing randomised trials for smaller populations. https://t.co/OtfeGRLW93
RT @MRCCTU: Take care compromising on power: Trial may be once-in-a-generation chance to help outcomes in a smaller population https://t.co…
RT @MRCCTU: Take care compromising on power: Trial may be once-in-a-generation chance to help outcomes in a smaller population https://t.co…
RT @MRCCTU: Take care compromising on power: Trial may be once-in-a-generation chance to help outcomes in a smaller population https://t.co…
RT @MRCCTU: Take care compromising on power: Trial may be once-in-a-generation chance to help outcomes in a smaller population https://t.co…
Take care compromising on power: Trial may be once-in-a-generation chance to help outcomes in a smaller population https://t.co/yYfMAb2DZq https://t.co/JSnXlDF2c5
RT @MarkKelson: Discussing this in our @CTRCardiffUni journal club led by @DaveGuk87 tomorrow. @tmorris_mrc @mattsydes https://t.co/p52LATt…
RT @MarkKelson: Discussing this in our @CTRCardiffUni journal club led by @DaveGuk87 tomorrow. @tmorris_mrc @mattsydes https://t.co/p52LATt…
RT @MarkKelson: Discussing this in our @CTRCardiffUni journal club led by @DaveGuk87 tomorrow. @tmorris_mrc @mattsydes https://t.co/p52LATt…
Discussing this in our @CTRCardiffUni journal club led by @DaveGuk87 tomorrow. @tmorris_mrc @mattsydes https://t.co/p52LATtT37
Mind the smaller populations gap! Use structured planning in your trial: https://t.co/yYfMAb2DZq
How do you design randomized trials for smaller populations? https://t.co/f7ASDkzr9C https://t.co/8sohpGeOS9
RT @MRCCTU: Considering a design for rare diseases? Have you pushed your original #RCT design as far as you can? https://t.co/yYfMAbkeQY
Considering a design for rare diseases? Have you pushed your original #RCT design as far as you can? https://t.co/yYfMAbkeQY
RT @MRCCTU: Is your trial falling down the 'small population' gap? This framework explores trial design for smaller populations https://t.c…
RT @tmorris_mrc: How do you design randomised trials for smaller populations? A framework Just out! Max Parmar, @mattsydes and me. https://…
RT @tmorris_mrc: How do you design randomised trials for smaller populations? A framework Just out! Max Parmar, @mattsydes and me. https://…
Nice article on small trial design, not likely to make big splash, but it is important. https://t.co/oCzVd57wEt
RT @MRCCTU: Is your trial falling down the 'small population' gap? This framework explores trial design for smaller populations https://t.c…
RT @MRCCTU: Is your trial falling down the 'small population' gap? This framework explores trial design for smaller populations https://t.c…
RT @MRCCTU: Is your trial falling down the 'small population' gap? This framework explores trial design for smaller populations https://t.c…
RT @MRCCTU: Is your trial falling down the 'small population' gap? This framework explores trial design for smaller populations https://t.c…
RT @MRCCTU: Is your trial falling down the 'small population' gap? This framework explores trial design for smaller populations https://t.c…
RT @MRCCTU: Is your trial falling down the 'small population' gap? This framework explores trial design for smaller populations https://t.c…
RT @MRCCTU: Is your trial falling down the 'small population' gap? This framework explores trial design for smaller populations https://t.c…
RT @MRCCTU: Is your trial falling down the 'small population' gap? This framework explores trial design for smaller populations https://t.c…
RT @MRCCTU: Is your trial falling down the 'small population' gap? This framework explores trial design for smaller populations https://t.c…
RT @MRCCTU: Is your trial falling down the 'small population' gap? This framework explores trial design for smaller populations https://t.c…
RT @MRCCTU: Is your trial falling down the 'small population' gap? This framework explores trial design for smaller populations https://t.c…
RT @MRCCTU: Is your trial falling down the 'small population' gap? This framework explores trial design for smaller populations https://t.c…
RT @MRCCTU: Is your trial falling down the 'small population' gap? This framework explores trial design for smaller populations https://t.c…
Is your trial falling down the 'small population' gap? This framework explores trial design for smaller populations https://t.co/QWjQQfaMWS https://t.co/UZVt0DgXTF
RT @pash22: How do you design randomised trials for smaller populations? A framework https://t.co/8227pvCTkv via @mattsydes
RT @pash22: How do you design randomised trials for smaller populations? A framework https://t.co/8227pvCTkv via @mattsydes
RT @pash22: How do you design randomised trials for smaller populations? A framework https://t.co/8227pvCTkv via @mattsydes
How do you design randomised trials for smaller populations? A framework https://t.co/8227pvCTkv via @mattsydes
RT @MRCCTU: How can we approach trial design when we can't get all the numbers for a randomised phase III trial? #Methodology https://t.co/…
RT @edinburghstroke: Agitating to make clinical trials better by concentrating on most important aspects of design & reducing regulation is…
RT @edinburghstroke: Agitating to make clinical trials better by concentrating on most important aspects of design & reducing regulation is…
RT @edinburghstroke: Agitating to make clinical trials better by concentrating on most important aspects of design & reducing regulation is…
RT @edinburghstroke: Agitating to make clinical trials better by concentrating on most important aspects of design & reducing regulation is…
Agitating to make clinical trials better by concentrating on most important aspects of design & reducing regulation is the key @More_Trials https://t.co/oIBkdIA3EC
How can we approach trial design when we can't get all the numbers for a randomised phase III trial? #Methodology https://t.co/QWjQQfsnOq https://t.co/lhrVksJB44
RT @MarionKCampbell: Lots of useful, practical tips to help design trials when you have small numbers. From @mattsydes and co... https://t.…
RT @MarionKCampbell: Lots of useful, practical tips to help design trials when you have small numbers. From @mattsydes and co... https://t.…
How do you design randomised trials for smaller populations? A framework. How should we approach trial design... https://t.co/GvuKol8fUv
RT @MarionKCampbell: Lots of useful, practical tips to help design trials when you have small numbers. From @mattsydes and co... https://t.…
RT @MarionKCampbell: Lots of useful, practical tips to help design trials when you have small numbers. From @mattsydes and co... https://t.…
RT @mattsydes: How to spend your Sat eve? Read: "How do you design randomised trials for smaller populations? A framework" https://t.co/W07…
RT @tmorris_mrc: How do you design randomised trials for smaller populations? A framework Just out! Max Parmar, @mattsydes and me. https://…
RT @MarionKCampbell: Lots of useful, practical tips to help design trials when you have small numbers. From @mattsydes and co... https://t.…
RT @tmorris_mrc: How do you design randomised trials for smaller populations? A framework Just out! Max Parmar, @mattsydes and me. https://…
RT @tmorris_mrc: How do you design randomised trials for smaller populations? A framework Just out! Max Parmar, @mattsydes and me. https://…
Excellent article on designing randomised trials for smaller populations @tmorris_mrc https://t.co/iH8XjVyZ6Z
RT @DrAndrewChoong: Thank you @MarionKCampbell & @Indovascular for the share & @mattsydes for the article. Fantastic read. https://t.co/AyN…
RT @DrAndrewChoong: Thank you @MarionKCampbell & @Indovascular for the share & @mattsydes for the article. Fantastic read. https://t.co/AyN…